Titan Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
Titan Pharmaceuticals, Inc. reported Earnings Per Share, Basic and Diluted of -$0.05 per share for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-11-16
- Titan Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.05.
- Titan Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.05.
- Titan Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.07.
- Titan Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2019-12-31 was $0.10.
- Titan Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2012 was -$0.23.
- Titan Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2011 was -$0.26.
- Titan Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2010 was -$0.09.
- Titan Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2009 was -$0.10.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$0.05 10-Q · filed 2020-11-16 | -$0.17 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | -$0.05 10-Q · filed 2020-08-14 | -$0.12 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | -$0.07 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | $0.10 derived: net income ÷ weighted average shares · filed 2021-03-31 | $0.57 derived: net income ÷ weighted average shares · filed 2021-03-31 | $3.52 derived: net income ÷ weighted average shares · filed 2021-03-31 | -$21.49 derived: net income ÷ weighted average shares · filed 2021-03-31 |
| 2019-09-30 | -$0.18 10-Q · filed 2020-11-16 | -$0.55 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.89 10-Q · filed 2020-11-16 | |
| 2019-06-30 | -$0.38 10-Q · filed 2020-08-14 | -$0.73 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | -$0.34 10-Q · filed 2020-05-15 | |||
| 2018-09-30 | -$0.64 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.89 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$1.62 derived: net income ÷ weighted average shares · filed 2019-11-14 | |
| 2018-06-30 | -$0.25 10-Q · filed 2019-08-14 | -$0.98 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$0.74 10-Q · filed 2019-05-15 | |||
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 | -$0.23 10-K · filed 2013-03-18 | ||
| 2012-09-30 | -$0.12 10-K · filed 2013-03-18 | -$0.23 10-Q · filed 2012-11-09 | ||
| 2012-06-30 | -$0.03 10-K · filed 2013-03-18 | -$0.11 10-Q · filed 2012-08-09 | ||
| 2012-03-31 | -$0.09 10-K · filed 2013-03-18 | |||
| 2011-12-31 | -$0.05 10-K · filed 2013-03-18 | -$0.26 10-K · filed 2013-03-18 | ||
| 2011-09-30 | -$0.01 10-K · filed 2013-03-18 | -$0.21 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | -$0.12 10-K · filed 2013-03-18 | -$0.19 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | -$0.08 10-K · filed 2013-03-18 | |||
| 2010-12-31 | -$0.09 10-K · filed 2013-03-18 | |||
| 2010-09-30 | -$0.01 10-Q · filed 2011-11-14 | -$0.04 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$0.03 10-Q/A · filed 2011-08-17 | -$0.04 10-Q/A · filed 2011-08-17 | ||
| 2009-12-31 | -$0.10 10-K · filed 2012-03-15 |